Semaglutide for Alzheimer's disease after evoke and evoke+

The Lancet 2026

View at publisher

Authors: Lon S Schneider

DOI: 10.1016/s0140-6736(26)00514-3

Cited by: 2

References: 12

Fields of Study & Subjects

Alzheimer's disease research and treatments Diabetes Treatment and Management Dementia and Cognitive Impairment Research

References 12